23.95 USD
▼-0.60-2.44%
盘后 24.15 +0.84%
2026-09-15
市值
$2.66B
市盈率
—
EPS
-2.48
股息率
—
52 周区间
8.93 – 30.06
成交量
1.33M
Beta
2.13
目标价
36.31
52W 低 8.9352W 高 30.06
价格走势
公司简介
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including I...